Page 948: In the symbol key in Figure 2A, “P = .57” should read “P = .057.” The corrected Figure 2A is shown below. The error has been corrected in the online version of the article.
Close modal
Figure 2.
Recombinant S100A9 proteins or upregulation of S100A9 by treatment of anti-IFNGRα antibodies reduce GVHD by altering donor cell trafficking. (A) Survival rate of mice treated with recombinant murine S100A9 with or without S100A8 proteins (1 μg/injection starting on day 0, 5 times per week for 2 weeks), after allo-HSCT.
Figure 2.
Recombinant S100A9 proteins or upregulation of S100A9 by treatment of anti-IFNGRα antibodies reduce GVHD by altering donor cell trafficking. (A) Survival rate of mice treated with recombinant murine S100A9 with or without S100A8 proteins (1 μg/injection starting on day 0, 5 times per week for 2 weeks), after allo-HSCT.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal